These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 22653923)

  • 1. Allosteric conversation in the androgen receptor ligand-binding domain surfaces.
    Grosdidier S; Carbó LR; Buzón V; Brooke G; Nguyen P; Baxter JD; Bevan C; Webb P; Estébanez-Perpiñá E; Fernández-Recio J
    Mol Endocrinol; 2012 Jul; 26(7):1078-90. PubMed ID: 22653923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing the functional link between androgen receptor coactivator and ligand-binding sites in prostate cancer and androgen insensitivity.
    He B; Gampe RT; Hnat AT; Faggart JL; Minges JT; French FS; Wilson EM
    J Biol Chem; 2006 Mar; 281(10):6648-63. PubMed ID: 16365032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Dynamics Simulations Revealed the Regulation of Ligands to the Interactions between Androgen Receptor and Its Coactivator.
    Liu N; Zhou W; Guo Y; Wang J; Fu W; Sun H; Li D; Duan M; Hou T
    J Chem Inf Model; 2018 Aug; 58(8):1652-1661. PubMed ID: 29993249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coregulator control of androgen receptor action by a novel nuclear receptor-binding motif.
    Jehle K; Cato L; Neeb A; Muhle-Goll C; Jung N; Smith EW; Buzon V; Carbó LR; Estébanez-Perpiñá E; Schmitz K; Fruk L; Luy B; Chen Y; Cox MB; Bräse S; Brown M; Cato AC
    J Biol Chem; 2014 Mar; 289(13):8839-51. PubMed ID: 24523409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A surface on the androgen receptor that allosterically regulates coactivator binding.
    Estébanez-Perpiñá E; Arnold LA; Nguyen P; Rodrigues ED; Mar E; Bateman R; Pallai P; Shokat KM; Baxter JD; Guy RK; Webb P; Fletterick RJ
    Proc Natl Acad Sci U S A; 2007 Oct; 104(41):16074-9. PubMed ID: 17911242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity.
    Elhaji YA; Stoica I; Dennis S; Purisima EO; Lumbroso R; Beitel LK; Trifiro MA
    Hum Mol Genet; 2006 Mar; 15(6):921-31. PubMed ID: 16449235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A conserved surface on the ligand binding domain of nuclear receptors for allosteric control.
    Buzón V; Carbó LR; Estruch SB; Fletterick RJ; Estébanez-Perpiñá E
    Mol Cell Endocrinol; 2012 Jan; 348(2):394-402. PubMed ID: 21878368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural features discriminate androgen receptor N/C terminal and coactivator interactions.
    Askew EB; Minges JT; Hnat AT; Wilson EM
    Mol Cell Endocrinol; 2012 Jan; 348(2):403-10. PubMed ID: 21664945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The T850D Phosphomimetic Mutation in the Androgen Receptor Ligand Binding Domain Enhances Recruitment at Activation Function 2.
    Helsen C; Nguyen T; Vercruysse T; Wouters S; Daelemans D; Voet A; Claessens F
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human androgen receptor gene ligand-binding-domain mutations leading to disrupted interaction between the N- and C-terminal domains.
    Jääskeläinen J; Deeb A; Schwabe JW; Mongan NP; Martin H; Hughes IA
    J Mol Endocrinol; 2006 Apr; 36(2):361-8. PubMed ID: 16595706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic communication between androgen and coactivator: mutually induced conformational perturbations in androgen receptor ligand-binding domain.
    Xu X; Yang W; Wang X; Li Y; Wang Y; Ai C
    Proteins; 2011 Apr; 79(4):1154-71. PubMed ID: 21322031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of allosteric modulators that disrupt androgen receptor co-activator protein-protein interactions to alter transactivation-Drug leads for metastatic castration resistant prostate cancer.
    Fancher AT; Hua Y; Close DA; Xu W; McDermott LA; Strock CJ; Santiago U; Camacho CJ; Johnston PA
    SLAS Discov; 2023 Oct; 28(7):325-343. PubMed ID: 37549772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor mutations identified in prostate cancer and androgen insensitivity syndrome display aberrant ART-27 coactivator function.
    Li W; Cavasotto CN; Cardozo T; Ha S; Dang T; Taneja SS; Logan SK; Garabedian MJ
    Mol Endocrinol; 2005 Sep; 19(9):2273-82. PubMed ID: 15919721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the homodimeric androgen receptor ligand-binding domain.
    Nadal M; Prekovic S; Gallastegui N; Helsen C; Abella M; Zielinska K; Gay M; Vilaseca M; Taulès M; Houtsmuller AB; van Royen ME; Claessens F; Fuentes-Prior P; Estébanez-Perpiñá E
    Nat Commun; 2017 Feb; 8():14388. PubMed ID: 28165461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An investigation into CAG repeat length variation and N/C terminal interactions in the T877A mutant androgen receptor found in prostate cancer.
    Southwell J; Chowdhury SF; Gottlieb B; Beitel LK; Lumbroso R; Purisima EO; Trifiro M
    J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):138-46. PubMed ID: 18619542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for DNA-binding domain--ligand-binding domain communications in the androgen receptor.
    Helsen C; Dubois V; Verfaillie A; Young J; Trekels M; Vancraenenbroeck R; De Maeyer M; Claessens F
    Mol Cell Biol; 2012 Aug; 32(15):3033-43. PubMed ID: 22645304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An examination of how different mutations at arginine 855 of the androgen receptor result in different androgen insensitivity phenotypes.
    Elhaji YA; Wu JH; Gottlieb B; Beitel LK; Alvarado C; Batist G; Trifiro MA
    Mol Endocrinol; 2004 Aug; 18(8):1876-86. PubMed ID: 15118070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Diversity of Ligand-Binding Androgen Receptors Revealed by Microsecond Long Molecular Dynamics Simulations and Enhanced Sampling.
    Duan M; Liu N; Zhou W; Li D; Yang M; Hou T
    J Chem Theory Comput; 2016 Sep; 12(9):4611-9. PubMed ID: 27560203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bridging structural biology and genetics by computational methods: an investigation into how the R774C mutation in the AR gene can result in complete androgen insensitivity syndrome.
    Wu JH; Gottlieb B; Batist G; Sulea T; Purisima EO; Beitel LK; Trifiro M
    Hum Mutat; 2003 Dec; 22(6):465-75. PubMed ID: 14635106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for the glucocorticoid response in a mutant human androgen receptor (AR(ccr)) derived from an androgen-independent prostate cancer.
    Matias PM; Carrondo MA; Coelho R; Thomaz M; Zhao XY; Wegg A; Crusius K; Egner U; Donner P
    J Med Chem; 2002 Mar; 45(7):1439-46. PubMed ID: 11906285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.